Will Those Who Get Vaccinated Against COVID-19 Be Injected With a Microchip?
A viral social media video insinuates that the COVID-19 vaccine contains trackable microchips that will be injected into vaccine recipients. The video, just under 4 minutes long, is a composite of clips from a number of different sources. Several of the clips have been edited to leave out important information. Together, they create a false impression that those who get vaccinated for COVID-19 will be injected with a “forced chip with a tracking device.”
The video begins with a clip of Bill Gates who appears to be saying: “… innovations like vaccines, we need a measurement system that tracks the vaccines.” The clip, which is edited and manipulated, is actually from the Alliance for Financial Inclusion’s Global Policy Forum in 2013, where Gates says “innovations like vaccines and high yielding crops have changed the future for billions of people.” He later mentions that “we need a measurement system that tracks the progress towards drawing people.” This “measurement system” he speaks of was not in reference to a vaccine, but rather was used in reference to “draw people in” to “benefit from financial activity.”
The viral video also uses a clip from the Christian Broadcasting Network from May, which talks about how “the U.S. government has contracted ApiJect Systems of America to make 100 million pre-filled syringes to quickly distribute a coronavirus vaccine.” The original clip also explains that there is space on each syringe “for an optional radio frequency identification chip containing a unique serial number for each dose. It would not be injected or touch the patient.”
The U.S. government did, in fact, make a deal with ApiJect to manufacture “injection devices” for a COVID-19 vaccine. According to a press release from the U.S. Department of Defense from May 2020, the Department of Defense and the U.S. Department of Health and Human Services announced a “$138 million contract with ApiJect Systems America for ‘Project Jumpstart’ and ‘RAPID USA,’ which together will dramatically expand U.S. production capability for domestically manufactured, medical-grade injection devices starting by October 2020.”